Hepatic Impairment Soon after oral administration of a single four mg dose (two mg hydromorphone quick-launch tablets), indicate publicity to hydromorphone (Cmax and AUC?) is elevated four-fold in individuals with reasonable (Youngster-Pugh Group B) hepatic impairment in contrast with subjects with regular hepatic functionality. Due to improved pub